The United States has long made substantial investments in clinical research with the goal
of improving the health and well-being of our nation. There is no doubt that these …

Although the consequences of population aging for growth in health expenditures have
been widely investigated, research on this topic is rather fragmented. Therefore, these …

This article describes the public health impact of Alzheimer's disease (AD), including
incidence and prevalence, mortality and morbidity, costs of care, and the overall impact on …

Background Existing models for forecasting future care needs are limited in the risk factors
included and in the assumptions made about incoming cohorts. We estimated the numbers …

A NEW YORK TIMES BESTSELLER “Brilliant and enthralling.”​—The Wall Street Journal A
paradigm-shifting book from an acclaimed Harvard Medical School scientist and one of …

Sharon R. Kaufman examines the quandary of patients, families and doctors not knowing
the point where enough medical treatment becomes too much treatment. A hidden chain of …

Medical practice in the United States has changed dramatically in the last several decades,
especially with more frequent use of prescription drugs. A higher volume and better-quality …

Purpose–This article aims to study the role of personal values as moderators of the
antecedents of consumers'“green” buying intentions in the context of Chinese consumers' …

Recent scientific advances suggest that slowing the aging process (senescence) is now a
realistic goal. Yet most medical research remains focused on combating individual diseases …

Alzheimer's disease (AD) extracts a heavy societal toll. The value of medical advances that
delay onset of AD could be significant. Using data from nationally representative samples …